-
In this issue: Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
-
Harada and colleagues from Japan conducted a double-blind, placebo-controlled, randomized multicenter trial of a low-dose oral contraceptive for the treatment of dysmenorrhea associated with endometriosis.
-
Among various agents that have been used to prevent preeclampsia, the ones that have attracted the greatest attention have been low-dose aspirin, calcium, and vitamins C and E.
-
Diagnostic ultrasonography is one of the most frequently utilized adjuvant tools clinicians rely upon to make treatment recommendations for suspect adnexal pathology.
-
Heat shock proteins have been of clinical interest in therapeutic vaccination based on their ability to induce significant T- and B-cell responses against microbial pathogens and tumor antigens.
-
The Timing Hypothesis argues that estrogen can reduce the risk of coronary heart disease when administered to relatively young postmenopausal women before atherosclerosis has developed to the stage of unstable plaques (plaques with necrosis and inflammation).
-
-
In this issue: Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.
-
Of note, this publication is a review article and not original science. The use of and possible indications for Computed Tomography (CT) scans have been rapidly growing since its introduction, particularly in the area of adult screening (ie, virtual colonoscopy, CT whole-body screening).
-
Michels and colleagues from the Nurses' Health Study searched for a link between the incidence of breast cancer and either induced or spontaneous abortions in their prospective cohort of 105,716 women.
